Prosmedic

One simple blood test
Final diagnosis within hours
Outstanding reliability

A game-changing diagnostic method

With a single blood test (ExoPro™), we can both determine and rule out presence of significant prostate cancer. The method is easy to adapt to existing laboratory automation systems. The current tests on the market can only show the potential risk of cancer and require further testing or biopsy to determine a final diagnosis. It is our expectation that the ExoPro™ shall require no further testing or biopsy.

How it works

Detection and diagnosis with one test

Our mission is to reduce prostate cancer mortality with a test truly suitable for screening and early detection.

The statistics that drive our scientists

Prostate cancer kills more men in Sweden than any other cancer

Standard prostate cancer diagnostic methods cause unnecessary suffering

Waiting for cancer diagnosis, regardless of outcome is very stressful. Standard methods include multiple steps that are both invasive, sometimes painful and require waiting. ExoPro™ is a single step process that only takes a few hours. The test will accurately tell presence of significant prostate cancer.

ProsMedic diagnostics Standard diagnostics

Huge amounts to be saved

The annual societal cost of prostate cancer worldwide is over 25 billion US dollars. By using ProsMedic's test, the costs will be significantly reduced.

Invest

Revolutionary prostate cancer diagnostics with one simple blood test

A game-changing diagnostic method

Our mission is to reduce prostate cancer mortality with a test truly suitable for screening and early detection.

Prostate cancer kills more men in Sweden than any other cancer

Standard prostate cancer diagnostic methods cause unnecessary suffering

The annual societal cost of prostate cancer worldwide is over 25 billion US dollars. By using ProsMedic's test, the costs will be significantly reduced.